Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-21

Clinical Trial Update: Glyceryl Eicosapentaenoate Based Topic Products as an Irritant-free Cream and Serum for Hydration of Sensitive Skin [NA]

View source ↗

Summary

SCF Pharma evaluated a glyceryl eicosapentaenoate-based topical cream/serum for hydrating sensitive skin. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glyceryl Eicosapentaenoate-based topical cream/serum (Glyceryl Eicosapentaenoate-based topical product)

Snippet

Sponsor: SCF Pharma | Conditions: Skin Dryness | NA | Status: TERMINATED